PATHOPHYSIOLOGY OF CYTOKINES

被引:15
作者
FRIDMAN, WH
MICHON, J
机构
[1] INSERM Unité 255, Institut Curie, Paris
关键词
capillary leak syndrome; cytokines; Interleukins; myeloma; toxicity;
D O I
10.1016/0145-2126(90)90092-N
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Beside their therapeutic effects, cytokines are involved in pathologies such as IL-6 in myeloma tumor growth and bone resorption, BCGF in the proliferation of hairy cell leukemic cells, IL-2 in the capillary leak syndrome. For biotherapy to develop, it is necessary to understand both the beneficial and the deletorious effects of cytokines. © 1990.
引用
收藏
页码:675 / 677
页数:3
相关论文
共 8 条
[1]   PASSIVE-IMMUNIZATION AGAINST TUMOR NECROSIS FACTOR PARTIALLY ABROGATES INTERLEUKIN-2 TOXICITY [J].
FRAKER, DL ;
LANGSTEIN, HN ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :1015-1020
[2]   A-B-CELL GROWTH FACTOR-DEPENDENT CELL-LINE DERIVED FROM A HUMAN LYMPHOCYTIC NODULAR LYMPHOMA [J].
GENOT, E ;
KOLB, JPB .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (01) :37-46
[3]   EXCESSIVE PRODUCTION OF INTERLEUKIN-6/B CELL STIMULATORY FACTOR-II IN RHEUMATOID-ARTHRITIS [J].
HIRANO, T ;
MATSUDA, T ;
TURNER, M ;
MIYASAKA, N ;
BUCHAN, G ;
TANG, B ;
SATO, K ;
SHIMIZU, M ;
MAINI, R ;
FELDMAN, M ;
KISHIMOTO, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (11) :1797-1801
[4]   CONSTITUTIVE PRODUCTION OF INTERLEUKIN-6 AND IMMUNOLOGICAL FEATURES IN CARDIAC MYXOMAS [J].
JOURDAN, M ;
BATAILLE, R ;
SEGUIN, J ;
ZHANG, XG ;
CHAPTAL, PA ;
KLEIN, B .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :398-402
[5]   AUTOCRINE GENERATION AND REQUIREMENT OF BSF-2/IL-6 FOR HUMAN MULTIPLE MYELOMAS [J].
KAWANO, M ;
HIRANO, T ;
MATSUDA, T ;
TAGA, T ;
HORII, Y ;
IWATO, K ;
ASAOKU, H ;
TANG, B ;
TANABE, O ;
TANAKA, H ;
KURAMOTO, A ;
KISHIMOTO, T .
NATURE, 1988, 332 (6159) :83-85
[6]   THE BIOLOGY OF INTERLEUKIN-6 [J].
KISHIMOTO, T .
BLOOD, 1989, 74 (01) :1-10
[7]   CLINICAL USE OF RECOMBINANT HUMAN HEMATOPOIETIC GROWTH-FACTORS [J].
LAVER, J ;
MOORE, MAS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (18) :1370-1382
[8]   A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
CHANG, AE ;
AVIS, FP ;
LEITMAN, S ;
LINEHAN, WM ;
ROBERTSON, CN ;
LEE, RE ;
RUBIN, JT ;
SEIPP, CA ;
SIMPSON, CG ;
WHITE, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897